Bioaccessibility in vitro tests measure the solubility of materials in surrogate biofluids. However, the lack of uniform methods and the effects of variable test parameters on material solubility limit interpretation. One aim of this study was to measure and compare bioaccessibility of selected economically important alloys and metals in surrogate physiologically based biofluids representing oral, inhalation and dermal exposures. A second aim was to experimentally test different biofluid formulations and residence times in vitro. A third aim was evaluation of dissolution behavior of alloys with in vitro lung and dermal biofluid surrogates. This study evaluated the bioaccessibility of sixteen elements in six alloys and 3 elemental/ metal powders. We found that the alloys/metals, the chemical properties of the surrogate fluid, and residence time all had major impacts on metal solubility. The large variability of bioaccessibility indicates the relevancy of assessing alloys as toxicologically distinct relative to individual metals.
Introduction
Alloy dust is a byproduct of the manufacturing and use of alloy materials such as stainless steel (SS). Occupational workers and to a lesser extent the general public are exposed to alloy and metal mixtures in dust. Normally regulatory agencies attempt to define and regulate risk of mixtures relative to the sum of the individual components (U.S.EPA, 2000; Vyskocil et al., 2004) but metal alloys are a unique class of substances defined as "consisting of two or more elements so combined that they cannot be readily separated by mechanical means" (Skeaff et al., 2007; UNGHS, 2005) . There are many alloys and each exhibits unique properties. Studies highlighting intrinsic differences in the solubility of metals in various alloys (Flint, 1998; Herting et al., 2008b; Skeaff et al., 2007; Stopford et al., 2003) recognize the significance of their unique qualities.
These studies indicate the importance of testing metal alloys separately from metal ores or minerals when classifying hazard.
Biologically relevant exposure tests measuring the chemical dose that is available for uptake are gaining greater attention and support for public health applications (Birnbaum, 2010) . One such exposure test, the bioaccessibility in vitro test, has been used to account for the relative bioavailability of contaminants in human health risk assessments (Brandon et al., 2006; Brock and Stopford, 2003; EN, 2009; Henderson et al., 2012; U.S.EPA, 2007) . Bioaccessibility is an important facet of bioavailability, and it is frequently defined as the biologically relevant fraction of a chemical that is potentially available for uptake into a biological organism (Anderson and Hillwalker, 2008; Brandon et al., 2006; Ruby et al., 1999) . The test only provides an estimate of the complex physiological and physicochemical processes that occur in human toxicokinetics, but represents the step in bioavailability that is most sensitive to the chemical behavior of materials (Brandon et al., 2006; Drexler and Brattin, 2007) .
Bioaccessibility in vitro tests, bio-elution, offer the advantages of simplicity, speed, affordability and ethical considerations over in vivo bioassays. Human surrogate biofluids used in bioaccessibility tests include gastro-intestinal (saliva, stomach, intestine), dermal (sweat), lung (alveolar, interstitial, lysosomal, serum) and internal implantation (lysosomal/cytosol). Oral bioaccessibility tests are the most frequently investigated with the test methodology ranging from a static gastric compartment (Drexler and Brattin, 2007; EN, 2002; Stopford et al., 2003; U.S.EPA, 2007) to dynamic gastrointestinal models (Garcia et al., 2001; Juhasz et al., 2009; Rodriguez and Basta, 1999; Ruby et al., 1996; VelascoReynold et al., 2008) . While multiple gastric methods persist, alloy dermal biofluid studies have generally used the EN 1811 reference method for allergenic responses via skin contact (Bocca et al., 2007; Flint, 1998; Julander et al., 2009; Midander et al., 2007b) . However, far fewer studies have applied in vitro bioaccessibility tests to lung (Herting et al., 2008b; Midander et al., 2007b; Stopford et al., 2003; Thelohan and Demeringo, 1994; Twining et al., 2005; Vitarella et al., 2000) or internal implantation (Herting et al., 2008a; Stopford et al., 2003) biofluids to assess inhalation exposure to alloys. A critical barrier to this type of testing is the lack of standardization for selecting physiologically-based extraction conditions including residence time, substance mass to biofluid volume ratio, agitation, and biofluid formulation chemistries. While some test parameters have been more thoroughly investigated, such as particle size, (Hedberg et al., 2010; Midander et al., 2007a ) test mass to biofluid ratio (Hamel et al., 1998; Thelohan and Demeringo, 1994) , and agitation (Midander et al., 2006) , other method variations, such as biofluid formulation and effect of residence time, are not as well characterized for use with alloys. These parameters are often manipulated between studies, making it difficult to compare bioaccessibility results and further preventing incorporation of a bioaccessibility test into health risk characterization.
This study evaluates metal bioaccessibility from several economically important grades of alloys in physiologically based in vitro biofluids representing three major exposure routes: gastric, lung and dermal. Biofluid formulations and residence times are two commonly employed test parameters that were evaluated using standard alloy reference materials. We illustrate that the in vitro bioaccessibility tests are applicable to assessing unique qualities of different alloy grades for health characterization purposes. We measure dissolution rates for nine alloys/metal powders in two biological surrogate biofluids. Six alloys and three elemental metal powders are compared using the major exposure route surrogate biofluids: gastric, lung and dermal.
Materials and methods

Materials
Four commercially available austenitic steel alloys and three metal powders were purchased from Atlantic Equipment Engineers (NJ, USA). The alloys included the American Iron and Steel Institute (AISI) stainless steel (SS) grades 316 and 304; the NieCr Inconel and NieCu Monel superalloys; and the metal powders included cobalt, manganese and nickel. Two alloy standard reference materials (SRMs) were purchased though National Institute of Standards and Testing (NIST, Gaithersburg, MD); SRM 101g (stainless steel, SS 304L) and SRM 14g (carbon steel). Table 1 lists the physical and chemical compositions of the alloys and metal powders.
Surrogate biofluids
Three human surrogate biofluids representing those involved in oral (gastric), inhalation (artificial lysosomal fluid [ALF]) and dermal (sweat) human exposure pathways were selected to measure alloy bioaccessibility. Different chemical formulations of the individual biofluids have been reported (Hedberg et al., 2010; Herting et al., 2007; Stopford et al., 2003) , however, the effects of different biofluid formulations have not received adequate attention. To evaluate the magnitude of the effects, two commonly reported versions of ALF and two versions of gastric biofluids were applied to the SRM alloys.
Gastric biofluids from the static gastric compartment model are simple surrogates with low pH levels (pH 1.2e1.5) representing a worst-case fasting exposure scenario for a conservative bioaccessibility assessment EN, 2009; Juhasz et al., 2009; U.S.EPA, 2007) . Two different gastric solution compositions were selected; a 0.07 N HCl solution further developed by Stopford et al. for determining metals in art material (ASTM, 2007; Stopford et al., 2003) and an approximately 1 N HCl solution buffered with 2.5 M glycine (herein described as gastriceGLY) used by the US EPA to assess gastric bioaccessibility of lead in soil (Drexler and Brattin, 2007) . This oral bioaccessibility model was selected because the static approach has undergone extensive inter-laboratory round robin testing (ASTM, 2007; Drexler and Brattin, 2007; EN, 2002; U.S.EPA, 2009 ) and validation with in vivo studies with soil matrices (Rodriguez and Basta, 1999; U.S.EPA, 2007) .
ALFs are composed of complex salts and organic acids with low pH (pH 4.5) simulating phagocytosis of particulates by lung alveolar cells and interstitial macrophages Thelohan and Demeringo, 1994) and inflammatory response connected with surgical implants in the body (Herting et al., 2008a) . Two ALF compositional differences reported in the literature include either the use of glycine (Thelohan and Demeringo, 1994) or an equivalent mass of glycerol , herein described as glycineeALF and glyceroleALF, respectively. Surrogate sweat (pH 6.4e6.6) that used was prepared according to the EN 1811 standardized test, which is commonly used for allergenic response from nickel, chromium, cobalt and other metals in alloys (Bocca et al., 2007; EN, 2009; Julander et al., 2009; Midander et al., 2007b) .
The complete compositions of the five biofluids used are listed in Supplementary information (SI) Table S1. All solutions were prepared using 18 MU cm water and analytical grade reagents and chemicals. ALF and sweat were used within a week and 3 h of preparation, respectively. The gastric fluids were considered stable throughout the study duration.
Experimental conditions
Test parameters evaluated included multiple formulations of biofluids and three residence times. Two formulations each for gastric and lung biofluids were tested. Gastric was tested with and without glycine (C 2 H 5 NO 2 ) and ALF was tested with glycine or glycerol (C 3 H 8 O 3 ). Complete compositions of all test biofluids are described in SI Table SI. Three residence times, 2, 24 and 72 h, were tested for lung and dermal biofluids and two residence times, 2 and 72 h were tested for gastric solutions, Table 2 and Fig. 1 . The gastric and glyceroleALF formulations were used for the residence time studies, Table 2 and Table S1 . All test parameters were performed with two SRMs, carbon steel (NIST 14g) and stainless steel (NIST 101g), which represent vastly different alloys.
We then evaluated the bioaccessibility of 4 alloys and 3 elemental metal powders in the following biofluids: gastric, lung and dermal (Table 3 ). Here we focused on one formulation and one residence time for each biofluid. Gastric employed HCl for 2 h, lung utilized ALF with glycerin for 72 h, and dermal sweat was tested as described above for 72 h.
The preparation consisted of 0.1 g (AE10%) of test alloy/metal powder with 50 mL of surrogate biofluid representing a 1:500 g/mL extraction ratio. This exposure ratio is associated with minimal solution saturation effects, increasing the potential for dissolution reproducibility even for soluble compounds (Hamel et al., 1998) . Each mixture was placed on an orbital shaker bath set at 100 oscillations min
À1
(3 cm Â 3 cm stroke path) at a temperature of 37 AE 2 C. Agitation was applied to the sweat biofluid for consistency amongst the methods through EN 1181 requires extraction without agitation. Exposure to light was minimized. The pH of the solution was monitored throughout the exposure period and adjusted to AE0.5 pH units of the expected level. At the end of the exposure, an aliquot was filtered through a PVDF 0.45 mm filter, representing an estimate of the dissolved fraction of the extract.
Extractions were prepared in duplicate or triplicate for the commercially available alloys and in triplicate or quintuplicate for the SRMs. All filtrates were stored at <4 C until analysis. Quality assurance protocols used included employing calibrated scales and transfer pipettes (verification of calibration prior to daily use) as well as class A volumetric glassware.
Metal analysis and quality control
Sixteen elements were quantified by inductively coupled plasma atomic emission spectroscopy (ICP-AES); aluminum, arsenic, barium, beryllium, cadmium, chromium, cobalt, copper, iron, lead, manganese, molybdenum, nickel, phosphorus, strontium and zinc. Detection limits ranged from 0.0014 to 0.016 mg/mL in the biofluid extract, from 0.70 to 8.0 mg/g in the metal and from 0.000070 to 0.00080 relative to % metal bioaccessibility; Supplemental information, Tables S2eS4. Quality control samples accounted for 30% of each batch and included reagent blanks, fortifications and instrument standard check samples. Recoveries of fortification samples and check standards were from 85 to 110% and 93 to 109%, respectively. The dissolution reproducibility was assessed by determining the bioaccessibility of all biofluids with three to five SRMs in a series of batches over the course of multiple days. The test procedures exhibited good reproducibility as indicated by low coefficients of variance across all batches for all biofluids, ranging from 0.087 to 0.36%.
Statistical analysis
Comparison of bioaccessibility between individual method modifications for each metal was carried out by a t-test. When data failed the equal variance test, a ManneWhitney rank sum test was applied. A p-value of <0.05 was considered statistically significant. All statistical calculations were performed using Sigmaplot v. 11 (Systat Software Inc., San Jose, CA, USA).
Results and discussion
Seven of the sixteen metals were frequently detected in the biofluid extracts of the nine alloys/metal powders tested: cobalt, chromium, copper, iron, manganese, nickel and zinc, SI Table S2 . To compare metal solubility across biofluids and alloys, bioaccessibility values were either normalized to the certified metal mass in the alloy (% metal ) in Tables 2 and 3 or relative to the mass of the alloy (% alloy ) which can be found in SI (Table S2) and Table 2 .
Most alloys are developed specifically to discourage corrosion or to encourage other unique properties. Pure metals or even soils are not sufficiently similar to alloys to be considered as a good proxy for evaluating the bioaccessibility of metals. Although soil SRMs have been used in bioaccessibility tests for comparisons (Hamel et al., 1998) , they would not be good surrogates to assess the effects of test parameters for bio-elution of alloys. We selected two distinctly dissimilar SRM alloys to assess different biofluid formulations and residence times.
Evaluation of in vitro biofluid testing modifications
Surrogate biofluid formulations
Two formulations of gastric biofluids were tested for a 2 h residence time, gastric with and without glycine (NH 2 CH 2 COOH), Table 2 . Ni, Cr and Fe were all slightly higher in the gastric glycine formulation, although there was no statistical difference between the two gastric formulations in stainless steel 304L (NIST 101g). However, Mn and Fe were lower in the gastric glycine formulation both by about a factor of 2 and statistically significant in carbon steel.
Two formulations of lung biofluids were tested: artificial lysosomal fluid (ALF) with glycine (NH 2 CH 2 COOH) or glycerol (C 3 H 8 O 3 ). In carbon steel the Cr and Fe were slightly lower in the glycine ALF formulation, while the Mn was about a factor of 10 lower in the glycine ALF. While the bioaccessibility data is limited due to many results being below detection limits (BDL), Ni and Cr do not appear to be especially sensitive to the formulations for the alloys tested. In contrast, the Mn and Fe results suggest that some metals in some alloys could be quite sensitive to these modest formulation . b Biofluid solutions prepared according to glycineegastric (Drexler and Brattin, 2007) . c Biofluid solutions prepared according to glycineeALF (Thelohan and Demeringo, 1994) ; all metals from SRM 304L NIST 101g were below detected limits in the sweat biofluid.
differences. Formulation differences are negligible for some metals and alloy reactivity may be comparable between studies using these two gastric biofluids. However, some metals appear to be sensitive to slight variations of biofluid composition.
Residence times
Three extraction times (2, 24, and 72 h) were tested in sweat and ALF (Fig. 1) . Two extraction times (2 and 72 h) were tested in the gastric biofluid (Table 2 ). Large differences between extraction times were observed for gastric biofluid for both alloys. In the carbon steel (NIST14g) we found that Co, Ni and Zn were BDL in the 2 h extracts but were significantly extracted by the 72 h test set. Similarly Co, Mn and Zn were BDL at 2 h in the stainless steel yet significantly extracted at 72 h. The extraction of Mn and Fe increased about 8-and 2-fold respectively from 2 to 72 h. Interestingly, both Cr and Ni increased about 60-fold from 2 to 72 h in the gastric biofluid and Fe increased about 50-fold. Like gastric, we found that several metals in ALF extracts were BDL at 2 h but detected at 72 h, specifically Cu, Ni and Zn in carbon steel and Co, Mn and Zn in stainless steel. We observed a 20-fold increase in Cr, a ] for SS316 (B), SS304 (>), Inconel (6) and Monel (✕) and the metal powders (fx1) exposed to ALF and sweat (EN, 2009) surrogate biofluids (n ¼ 2 or 3).
90-fold increase in Mn and a 25-fold increase in
Fe between 2 and 72 h with ALF in the carbon steel. Unlike gastric and ALF, few metals were extracted at either residence time from the sweat biofluid. As expected the dermal bioaccessibility of many metals was BDL in sweat biofluid at both residence times, including Co, Cr, Cu, Ni and Zn. Mn, however, had a 3-fold increase from 2 to 72 h residence time in sweat. Different residence times have been used in bioaccessibility studies. Data from bioaccessible gut fluid tests with longer residence times have been used to calculate conservative risk rankings after incorporation in threshold ingestions (Twining et al., 2005) . However, use of a gastric residence time longer than 3 h is not physiologically appropriate (Twining et al., 2005) . Unlike gastric, lung and sweat multi-day residence times generally are physiologically supported (Chen and Lippmann, 2009) . Bioaccessibility tests investigating surrogate lung biofluids have been conducted from 2 to 72 h (Midander et al., 2007b; Stopford et al., 2003; Vitarella et al., 2000) while even longer times are used in some standardized sweat bioaccessibility methods, such as a seven day exposure period (EN, 2009) .
The upper limits of bioaccessibility (% metal ) may have been reached for several metals at 72 h. In the gastric biofluid Co, Mn and Ni were !25% for carbon steel and !23% for Co, Cr and Ni in stainless steel (NIST 101g), Table 2 . More dramatic than gastric extraction, the upper limits of bioaccessibility for the ALF biofluid may have been reached at !74% for Cr, Cu, Mn and Ni for the carbon steel, in contrast to the ALF 72 h residence time extractions for the stainless steel (NIST 101g). The metal bioaccessibility was <1% for all metals tested in stainless steel (NIST 101g) after 72 h in ALF biofluid. These results are consistent with the known physicale chemical properties of the two alloy grades used.
We intentionally chose two distinctly different types of steels to reveal the potential difference the changes in test parameters might have on different alloys. The carbon steel (NIST14g) has poor corrosion resistance while the stainless steel (NIST 101g) is equivalent to a 304 alloy grade which has strong corrosion resistance. This corrosion resistant characteristic is primarily associated with >10% by weight of Cr and Ni. Many alloys dissolve incongruently, meaning the composition of the solid and the dissolved solute do not stoichiometrically match (Herting et al., 2008b; Midander et al., 2007a) . Solubilization of metals from alloys is accompanied by alteration of the alloy and possibly formation of a secondary solid phase on the alloy surface consisting of oxides and/or hydroxides. This alteration may take the form of a passive surface film of Cr (III) oxide as a secondary solid phase formed on the surface. With continuous aqueous exposure the secondary oxide solid phase acts as a surface barrier against additional metal dissolution (Hedberg et al., 2010; Herting et al., 2008b; Midander et al., 2007a) . Our results are consistent with incongruent solubilization and oxide surface film formation for the high Cr test sample, stainless steel (NIST 101g). The effect of changing residence times had distinctly different effects on the two different alloys. If only corrosion resistant steels are evaluated with various biofluid formulations and test parameters, then only modest differences might be observed. For example, the ALF 2 h and 72 h are only slightly changed for stainless steel, but are vastly different for carbon steel. Residence times had a profound effect on biofluids and test materials evaluated, but these effects depended strongly on the alloy.
Comparison of in vitro surrogate gastric, lung and dermal biofluids
All biofluids used for this study are acidic, ranging from near neutral to highly acidic: sweat (pH 6.5), ALF (pH 4.5), and gastric (pH 1.2). The lowest bioaccessibility was observed for sweat, Tables 2 and 3 . Comparing ALF with gastric at 2 h extraction time, we found that Cr was higher in ALF while Mn was lower in ALF in carbon steel alloy. In contrast, at 2 h the stainless steel results suggest potentially higher Cr and Ni in gastric than ALF although due to slight differences in detection limits this is not conclusive. However, comparing the 72 h gastric with ALF we find that ALF had substantially higher bioaccessibility for Cr, Cu, Mn and Ni in carbon steel. In contrast the gastric extracts were higher than ALF extracts from stainless steel for Co, Cr, Mn and Ni. Depending on the alloy the relative bioaccessibility of metals is not simply a function of acidity. While typically more acidic biofluids are associated with greater release of metals from alloys/metals (Midander et al., 2007b; Stopford et al., 2003) and soils (Oomen et al., 2002) we observed high bioaccessibility in ALF for some metals in some 16 AE 2 n a n a n a n a n a ALF 30 AE 2 n a n a n a n a n a sweat 1. alloys. The ALF is composed of several complexing salts and agents, such as organic acids, that have been shown to weaken covalent bonds in the metal oxide and hydroxide surface layers, resulting in the release of metaleligand complexes (Hedberg et al., 2010) . This is likely associated with increased chemical dissolution of alloys in the ALF solution as compared to the gastric and sweat solutions.
Evaluation of dissolution behavior of alloys with in vitro lung and dermal surrogates
Dissolution kinetics was investigated in ALF and sweat biofluids for the commercially available alloys to evaluate reactivity (Fig. 1) . The rates of dissolution for Mn, Co, Cr and Fe were similar to those reported by other studies of metal alloys exposed to lung and sweat biofluids (Herting et al., 2008a, b; Midander et al., 2007a Midander et al., , 2007b . Maximum early release was followed by fast dissolution quickly approaching steady-state by 24 h. Fast dissolution approaching steady-state in 24 h has been reported in other studies of metal alloys exposed to lung and sweat biofluids (Herting et al., 2008a, b; Midander et al., 2007a Midander et al., , 2007b . Metal release over time may be reduced by the formation of an oxide passive surface layer in corrosive resistant materials as discussed above. Potentially other surface chemistries such as calcium and/or phosphate film(s) on the surfaces of particles exposed to lung biofluids (Midander et al., 2007b) may also influence bioaccessibility reduction. The formation of passive surface layer formation on metal composites has been shown to be time dependent (Chen et al., 1999) .
In the ALF extracts Cu and Ni from the metal powders, and Ni from Monel suggest a possible bi-phase dissolution behavior comprised of an initial increase from 2 to 24 h with a slow decline. This could also suggest alloy/metal incongruent solubilization and new oxide, phosphide and/or calcium solid surface formation. We observe different solubilization with time consistent and suggestive of changes in the surface chemistries. Certainly an assessment of multiple time points to attain relative steady-state behavior of different alloy grades is relevant for characterizing exposure over time and appears prudent for a complete human health exposure characterization.
The dissolution results are consistent with the known alloy properties. For example, high corrosion resistant alloys had minimal release of Cr and Fe and were BDL for all other metals tested. In contrast, bioaccessibility rates of Mn, Co, Ni and Cu for the Monel alloy, poor corrosive resistant alloys, and the metal powders were significantly higher. The differences between alloys and dissolution rates are profound. Several orders of magnitude differences in ALF (0.004e16% h À1 ) and the sweat biofluid (0.02e0.14% h À1 ) were observed.
Comparisons of bioaccessibility of metals from nine alloys/ metal powders in surrogate biofluids
Tables 2 and 3 summarize the metal bioaccessibility results (% metal ) for gastric (2 h), and ALF and sweat (72 h), surrogate biofluids. The corrosion resistant samples, stainless steels 304, 316, Inconel and NIST 101g, had low bioaccessibility of metals for all three biofluids. Many metals were BDL for the corrosion resistant alloys. For instance, Cr, Cu, Fe, Mn, Ni were <0.3% metal in gastric biofluid. In contrast, in the poor or moderately corrosion resistant alloys and elemental metal powders we found several metals to be significantly more bioaccessible. In the Monel sample Ni, Fe and Cu had 2.77, 3.43 and 3.87% metal respectively in gastric biofluid. Unlike gastric biofluid extracts, ALF extractions of the corrosion resistant stainless steels (304, 316, Inconel and NIS101g) had low to moderate bioaccessibility. While some ALF extracts were low for corrosive resistant steels, some were notably higher. For example, Cu in Inconel was about 8%, Mn in SS316 was over 4% and finally Ni in SS304 was 1.79% bioaccessible. The ALF extracts of the noncorrosive alloys were quite high for some metals, as previously discussed above for carbon steel. In addition, the Monel Cu and Ni were 30 and 25.7% metal respectively for ALF extracts. As expected, the elemental metal powders (Co-metal, Mn-metal and Ni-Metal) were found to have very high bioaccessibilities relative to the alloys for all biofluids, Table 3 . The % metal bioaccessibility for any given alloy for a given biofluid ranged widely, Tables 2 and 3. As but one example, Ni in gastric was about 0.067% metal for the Inconel alloy and 2.77% metal for the Monel alloy, over a 40-fold difference. Other than the elemental metal powders the sweat biofluids resulted in little bioaccessibility, typically BDL. The exceptions were in the Monel alloy where both Cu and Ni were found to be about 2 and 1% metal , respectively.
The metal alloy bioaccessibility levels overall were lowest in the corrosion resistant SS 304, 316, NIST 101g, and then Inconel. The poor corrosion resistant steels Monel and carbon steel were found to have overall the highest bioavailabilities. The corrosion resistant stainless steel alloys contained >11% chromium composition by mass which provides a protective chromium-rich oxide layer and limits metal release. The carbon steel and Monel alloy have little to no Cr and were characterized with higher bioaccessibility for many metals and biofluids. While the higher Ni content in the Monel compared to the carbon steel provided some protection from solubilization of metals in the biofluids, this effect was not as strong as seen with the Cr-containing alloys. The Monel and carbon steel alloys and the elemental metal powders can be considered more reactive than the other stainless steels tested.
With six alloys and three elemental metal powders tested on average for 72 h residence times, the sweat extraction resulted in the lowest bioaccessibility and the ALF the highest bioaccessibility. Although the gastric was the most acidic of the biofluids tested, it did not result in the highest bioaccessibility because the physiologically-based residence time of 2 h was used. Within the physiologically-based approach the dominant factor in determining bioaccessibility was the reactivity of the individual alloys.
The potential impact of the bioaccessibility test on hazard classification of alloys is important as increasingly greater incidences of cancer and non-cancer health risks are associated with workplace (Gorell et al., 1999) and urban (Willis et al., 2010) exposure from ambient metal generated in industrial metal facilities. The bioaccessibility of metals from the elemental metal powders was much higher than from the metal in the alloys. For example the Co, Ni and Mn elemental metal powders were at least 10-fold higher than the corresponding metal bioaccessibility from any of the alloys, Table 3 . These results illustrate and support that alloy grades have unique chemical reactivity that is not adequately explained by their individual metal compositions. For example, the solubility may be over-estimated, as is the case for Mn and Co in the more reactive alloys, or under-estimated, as for Ni in the less reactive alloy grades.
Conclusion
These results support testing alloy grades as unique from their metal components to avoid over or under-estimating their health risk to humans. All alloy grades, independent of biofluid, revealed time-dependent release. We demonstrated the value of using distinctly different standardized alloy materials ranging in reactivity and/or corrosion resistance to determine the sensitivity of test parameters within bioaccessibility methods. What may seem like minor changes in biofluid formulations may have significant effects on bioaccessibility. This was demonstrated with Mn in the gastric with and without glycine and the ALF with glycine or glycerol. The dissolution studies illustrated the profound effects that alloy characteristics and media have on metal dissolution. These studies measured and compared metal solubility in a series of alloys and elemental metal powders in various surrogate biofluids. They yield data that are useful in improving estimates of exposure to these materials.
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